ISCT peer-reviewed paper on Critical elements in the development of cell therapy potency assays for ischemic conditions.
You may also be interested in:
Allogeneic
Autologous
iPSCs
Analytical Development
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.
Latest briefing from the Knowledge Center
Article
The Evolving Landscape of ADC Analytical Development
Lentivirus modeled above hand
White paper
Xcite®: an optimized transient transfection platform to accelerate your AAV program from gene to...
Unlock the full potential of your AAV program with Xcite®: a proven path from gene to GMP by being...
Lonza Bend Solid Form Services
Webinar (on-demand)
Amorphous Solid Dispersions (ASDs): Pre-clinical to Commercial Capabilities
Is your drug candidate struggling with solubility, slowing down its path to market?...
Capsule services
White paper
Unlock key insights of end-to-end regulatory CDMO solutions
Navigating the complex world of drug development and regulatory approval just got easier. Our recent...
Webinar (on-demand)
Lonza's integrated ADC offering: From concept to commercialization
As the Antibody-Drug Conjugate (ADC) market continues its robust expansion, the demand for...
Used as thumbnail for Powder to Particles podcast.
Webinar (on-demand)
Solving the inhalation puzzle: A CDMO's guide to dry powder development
Unlock the secrets to successful pulmonary and nasal drug delivery with our exclusive on-demand...
Mammalian Biologics Drug Substance Manufacture MC1
Webinar (on-demand)
Navigating the CMC regulatory landscape during protein medicinal product development and...
Explore the evolving regulatory landscape for protein-based therapeutics in this on-demand webinar....
man working with microscope in lab,Process Development,Biologics_Slough_18,,lab in slough,tech working in lab with computer,male tech pipetting,tech holding vial,tech working,Cell Iine process development,biologics lab worker, ,Biologics_Slough_29,Biologics , Biologics Slough
CDMO Notes Blog post
Fit-for-purpose analytical methods to accelerate the development and manufacture of new molecular...
Learn how Lonza's experts develop fit-for-purpose analytical methods to ensure quality, consistency,...
CDMO Notes Blog post
Smarter expression approaches for multi-chain therapeutic protein formats
Our customers play a critical role in driving innovation, often advancing multi-chain and new...
R&D Blog post
Monitoring residual host cell proteins in pharmaceutical products to ensure patient safety
Biologics manufacturing mostly relies on host organisms, such as Chinese hamster ovary (CHO) cells...
Podcast
A View On Microbial Manufacturing (S04 E06)
In this episode, we hear from Karlheinz Flicker and Joan Cortada, two experts from Lonza's microbial...
Lonza Bend Early Phase
White paper
Precision in miniature: optimizing multiparticulate formulations for pediatric oncology
This white paper details a collaborative effort between Lonza’s Bend, OR site and Pfizer’s Groton,...